Table of Contents

April 22, 2004
Volume 47, Issue 9
Pages 2171-2392

About the Cover: Molecular modeling of overlayed trisubstituted acridine derivatives (mauve and green) complexed with G-quadruplex DNA (Harrison, R. J.; et al. J. Med. Chem. 2003, 46, 4463-4476).

Letters

Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators

pp 2171–2175
Publication Date (Web): March 20, 2004 (Letter)
DOI: 10.1021/jm034243o

Selective, Orally Active γ-Aminobutyric AcidA α5 Receptor Inverse Agonists as Cognition Enhancers

pp 2176–2179
Publication Date (Web): March 27, 2004 (Letter)
DOI: 10.1021/jm031076j

Articles

Synthesis and Selective Cyclooxygenase-2 Inhibitory Activity of a Series of Novel, Nitric Oxide Donor-Containing Pyrazoles

pp 2180–2193
Publication Date (Web): March 27, 2004 (Article)
DOI: 10.1021/jm030276s

Identification of Putative Agouti-Related Protein(87−132)-Melanocortin-4 Receptor Interactions by Homology Molecular Modeling and Validation Using Chimeric Peptide Ligands

pp 2194–2207
Publication Date (Web): March 20, 2004 (Article)
DOI: 10.1021/jm0303608

Synthesis and Evaluation of Two 18F-Labeled 6-Iodo-2-(4‘-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine Derivatives as Prospective Radioligands for β-Amyloid in Alzheimer's Disease

pp 2208–2218
Publication Date (Web): March 20, 2004 (Article)
DOI: 10.1021/jm030477w

Comparative Molecular Field Analysis and Comparative Molecular Similarity Indices Analysis of Thalidomide Analogues as Angiogenesis Inhibitors

pp 2219–2227
Publication Date (Web): March 27, 2004 (Article)
DOI: 10.1021/jm0304820

Development of a New Radioligand, N-(5-Fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for PET Imaging of Peripheral Benzodiazepine Receptor in Primate Brain

pp 2228–2235
Publication Date (Web): March 26, 2004 (Article)
DOI: 10.1021/jm0304919

Synthesis, Biological Activity, and Quantitative Structure−Activity Relationship Study of Azanaphthalimide and Arylnaphthalimide Derivatives

pp 2236–2242
Publication Date (Web): March 20, 2004 (Article)
DOI: 10.1021/jm0310784

Novel Amino Acid Derived Natural Products from the Ascidian Atriolum robustum:  Identification and Pharmacological Characterization of a Unique Adenosine Derivative

pp 2243–2255
Publication Date (Web): March 30, 2004 (Article)
DOI: 10.1021/jm031092g

Synthesis and Structure−Activity Relationship of Novel Antitumoral Platinum Xanthate Complexes

pp 2256–2263
Publication Date (Web): March 20, 2004 (Article)
DOI: 10.1021/jm0309405

Heterocyclic Bis-Cations as Starting Hits for Design of Inhibitors of the Bifunctional Enzyme Histidine-Containing Protein Kinase/Phosphatase from Bacillus subtilis

pp 2264–2275
Publication Date (Web): March 26, 2004 (Article)
DOI: 10.1021/jm021043o

Combination of Paclitaxel and Nitric Oxide as a Novel Treatment for the Reduction of Restenosis

pp 2276–2282
Publication Date (Web): March 26, 2004 (Article)
DOI: 10.1021/jm0304111

Structure−Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA Polymerase

pp 2283–2295
Publication Date (Web): March 26, 2004 (Article)
DOI: 10.1021/jm030424e

Bisguanidine, Bis(2-aminoimidazoline), and Polyamine Derivatives as Potent and Selective Chemotherapeutic Agents against Trypanosoma brucei rhodesiense. Synthesis and in Vitro Evaluation

pp 2296–2307
Publication Date (Web): March 26, 2004 (Article)
DOI: 10.1021/jm031024u

4-(Tetralin-1-yl)- and 4-(Naphthalen-1-yl)alkyl Derivatives of 1-Cyclohexylpiperazine as σ Receptor Ligands with Agonist σ2 Activity

pp 2308–2317
Publication Date (Web): March 30, 2004 (Article)
DOI: 10.1021/jm031026e

Design, Synthesis, and Biological Evaluation of Substituted 2-Cyclohexyl-4-phenyl-1H-imidazoles:  Potent and Selective Neuropeptide Y Y5-Receptor Antagonists

pp 2318–2325
Publication Date (Web): March 20, 2004 (Article)
DOI: 10.1021/jm030490g

Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3:  Synthesis and Immunosuppressive Activity

pp 2326–2336
Publication Date (Web): March 05, 2004 (Article)
DOI: 10.1021/jm030523s

Carbonic Anhydrase Inhibitors. Design of Selective, Membrane-Impermeant Inhibitors Targeting the Human Tumor-Associated Isozyme IX

pp 2337–2347
Publication Date (Web): March 20, 2004 (Article)
DOI: 10.1021/jm031079w

Dopamine D4 Ligands and Models of Receptor Activation:  2-(4-Pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and Related Heteroarylmethylarylpiperazines Exhibit a Substituent Effect Responsible for Additional Efficacy Tuning

pp 2348–2355
Publication Date (Web): March 23, 2004 (Article)
DOI: 10.1021/jm0305669

Application of Predictive QSAR Models to Database Mining:  Identification and Experimental Validation of Novel Anticonvulsant Compounds

pp 2356–2364
Publication Date (Web): March 20, 2004 (Article)
DOI: 10.1021/jm030584q

Synthesis and Biological Activity of Sulfonamide Derivatives of Epipodophyllotoxin

pp 2365–2374
Publication Date (Web): March 30, 2004 (Article)
DOI: 10.1021/jm031117b

Design of Potent and Selective Agonists for the Human Vasopressin V1b Receptor Based on Modifications of [Deamino-Cys1]arginine Vasopressin at Position 4

pp 2375–2388
Publication Date (Web): March 30, 2004 (Article)
DOI: 10.1021/jm030611c

Brief Articles

Structural and Energetic Analyses of the Effects of the K103N Mutation of HIV-1 Reverse Transcriptase on Efavirenz Analogues

pp 2389–2392
Publication Date (Web): March 20, 2004 (Brief Article)
DOI: 10.1021/jm0303507